Arena Blog

In 2021 Square and ARK argued that bitcoin miners would be the grid's most flexible customer and speed up solar and wind. Five years on, the grid queue has doubled, the network uses about as much power as then, and listed miners have signed more than $70 billion in AI contracts. What are you buying with a mining stock?

Altcoin breadth tells you how many coins are above their 200-day line, and the answer depends on which coins are counted. Since 2018 the 100 most-traded came out ahead on 72% of days, recently 70% against 40% for all altcoins. Which number applies to the coin you hold?

A network's value grows with the square of its participants — says Metcalfe's Law. Where it came from, where it was ever measured, why it describes 15 years of Bitcoin well, and why the "seven-year low in active addresses" headline still counts no users.

The Richmond Fed tested 30 years of income data against a strict definition: a K appeared in 2002–06 and 2010–13, not after COVID. Why short stretches still last, and why no average can show one.

Trump announced tariffs, $19 billion was force-sold — and three days later the market looked normal again. Sorting the occasion from the cause.

The 2/28 mortgage worked because the collateral appreciated. A GPU cannot do that. What the 2006 comparison holds up to once you put the numbers side by side.

The holder count for tokenized equities nearly doubled in thirty days. Value per holder has halved since March. Both are true, and together they say something neither says alone.

The copper/gold ratio is sold as a macro and Bitcoin signal. What it actually measures, where it fails, and why a viral "Bitcoin cycle" indicator built on it has look-ahead bias.

The Fed looks trapped: fight inflation with high rates, or refinance the debt cheaply. But it already resolved part of that bind — by decoupling its tools. A methodical read on what this means for Treasuries.

The "hacked again" reflex is wrong. What the Polymarket case actually shows — and the two places where crypto genuinely is harder.

"Invested in AI healthcare" can mean two almost opposite things. Two real companies show it: an annuity machine with ~86% recurring revenue — and an option with not a single approved drug. Same label, opposite risk DNA.

"Price gaps always fill" is a myth. What the evidence actually shows — for stock gaps, and for the CME gap, which became history in May 2026.